Therapeutic potential of mesenchymal stem cells for peripheral artery disease in a rat model of hindlimb ischemia

Therapeutic potential of mesenchymal stem cells for peripheral artery disease in a rat model of hindlimb ischemia

Objective(s): Mesenchymal stem cells are viewed as the first choice in regenerative medicine. This study aimed to elucidate the influence of BM-MSCs transplantation on angiogenesis in a rat model of unilateral peripheral vascular disease. Materials and Methods: Twenty-one rats were arbitrarily alloc...

Full description

Bibliographic Details
Main Authors:	Amani Ali, Amira Ahmed, Dina El-Yasergy, Moustafa Abousarie, Ramadan Elsayed, Yasmin Mohammed, Rahab Mohammed
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2021-06-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	cxc chemokine receptor 4 mesenchymal stem cells peripheral vascular disease vascular endothelial growth factor receptor 2 von willebrand factor
Online Access:	https://ijbms.mums.ac.ir/article_18023_e785b737f686976e40f99df0b7881b22.pdf

Similar Items

Genetic Polymorphisms of CXCL8 (−251) Are Associated with the Susceptibility of Helicobacter pylori Infection Increased the Risk of Inflammation and Gastric Cancer in Thai Gastroduodenal Patients
by: Wongwarut Boonyanugomol, et al.
Published: (2019-08-01)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
by: Alireza Nazari, et al.
Published: (2020-03-01)

Targeting G protein-coupled receptor for pain management
by: Hongyan Li, et al.
Published: (2017-01-01)

Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment
by: Jing-Yi Chen, et al.
Published: (2019-08-01)

A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01)

CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
by: Lu Wang, et al.
Published: (2020-02-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation
by: Xuan Tao, et al.
Published: (2019-03-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

Generation of the neutrophil chemoattractant interleukin-8 in inflammatory models of the rabbit heart and lung
by: Chivers, Simon
Published: (1999)

Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation
by: Sung-Tai Wei, et al.
Published: (2021-05-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021-04-01)

Analysis of SDF-1/CXCR4 pathway function in osteosarcoma and the regulating effect of exogenous SDF-1 on osteosarcoma cells
by: Ding-Tian Liang, et al.
Published: (2016-04-01)

Chemotactic Cues for NOTCH1-Dependent Leukemia
by: Erich Piovan, et al.
Published: (2018-04-01)

Investigating the Genetic Basis of Type 3 of Von Willebrand Disease (VWD)
by: Bowman, MACKENZIE
Published: (2013)

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
by: Pikta Marika, et al.
Published: (2021-01-01)

Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts
by: Patrícia Alvarez Ruiz, et al.
Published: (2010-12-01)

CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway
by: Jia-Hui Gao, et al.
Published: (2019-12-01)

Development of von Willebrand Factor Zebrafish Mutant Using CRISPR/Cas9 Mediated Genome Editing
by: Toffessi Tcheuyap, Vanina
Published: (2017)

Vascular endothelial growth factor and chemokine receptor-3 in the pathogenesis of pterygium
by: Hui Liu, et al.
Published: (2019-04-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
by: Michelle Sholzberg, et al.
Published: (2021-07-01)

Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression
by: Min Jae H, et al.
Published: (2012-07-01)

CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1
by: Zhao D, et al.
Published: (2019-12-01)

The CXC Chemokine Receptors in Four-Eyed Sleeper (<i>Bostrychus sinensis</i>) and Their Involvement in Responding to Skin Injury
by: Mengdan Dong, et al.
Published: (2021-09-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

Effect of Levothyroxine Administration on Hemostatic Analytes in Doberman Pinschers with von Willebrand's Disease
by: Heseltine-Heal, Johanna Colleen
Published: (2014)

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
by: T V Antonova, et al.
Published: (2013-12-01)

The Influence of Zearalenone on Selected Hemostatic Parameters in Sexually Immature Gilts
by: Ewa Jakimiuk, et al.
Published: (2021-09-01)

The Osteoprotegerin - Von Willebrand Factor Complex: Protagonist Or Bystander In Atherothrombosis?
by: Nagy Elod
Published: (2016-06-01)

Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data
by: Paul Harper, et al.
Published: (2016-04-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
by: Jessica Garcia, et al.
Published: (2020-01-01)

Active von Willebrand Factor in patients with a bleeding diathesis
by: Lisa N. van der Vorm, et al.
Published: (2020-12-01)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2020-10-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
by: Boshagh MA, et al.
Published: (2019-06-01)

CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions
by: Mohammad Hassan Mohammadi, et al.
Published: (2021-06-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)